A prime example is the gene therapy drug Luxturna, which delivers normal copies of the RPE65 gene to retinal cells, improving vision in patients with RPE65 deficiency (Leroy et al., 2023). This evidence concerns the gene RPE65 and hyperinsulinemic hypoglycemia, familial, 4.